Article Information
History
- March 2, 2022.
Article Versions
- You are currently viewing Version 1 of this article (March 2, 2022 - 10:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tom Jefferson1,*,
- Elizabeth A. Spencer2,
- Elena C. Rosca3,
- Susanna Maltoni4,
- Jon Brassey5,
- Igho J. Onakpoya1,
- Annette Plüddemann2,
- David H. Evans6,
- John M. Conly7 and
- Carl J. Heneghan2
- 1Department for Continuing Education, University of Oxford, UK
- 2Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK
- 3Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
- 4Division of Research and Innovation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
- 5Trip Database Ltd, Newport, UK
- 6Li Ka Shing Institute of Virology and Dept. of Medical Microbiology & Immunology, University of Alberta, Canada
- 7Departments of Medicine, Microbiology, Immunology & Infectious Diseases, and Pathology & Laboratory Medicine, Synder Institute for Chronic Diseases and O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada
- ↵*Corresponding author; email: tom.jefferson{at}conted.ox.ac.uk
Posted March 02, 2022.
Viral cultures, Polymerase Chain Reaction Cycle Threshold Values and Viral Load Estimation for SARS-CoV-2 Infectious Potential Assessment in Hematopoietic Stem Cell and Solid Organ Transplant Patients: A Systematic Review
